Pharmacokinetics of Gefitinib in a Patient with Non-Small Cell Lung Cancer Undergoing Continuous Ambulatory Peritoneal Dialysis

@inproceedings{Yamaguchi2015PharmacokineticsOG,
  title={Pharmacokinetics of Gefitinib in a Patient with Non-Small Cell Lung Cancer Undergoing Continuous Ambulatory Peritoneal Dialysis},
  author={Teppei Yamaguchi and Sumito Isogai and Takuya Okamura and Sakurako Uozu and Yuki Mieno and Tami Hoshino and Yasuhiro Goto and Masamichi Hayashi and Toru Nakanishi and Kazuyoshi Imaizumi},
  booktitle={Case reports in oncology},
  year={2015}
}
A 72-year-old man undergoing continuous ambulatory peritoneal dialysis (CAPD) for chronic renal failure and who had undergone right upper lobectomy for lung adenocarcinoma (pT2aN0M0) 2 years ago was admitted for recurrence of lung cancer presenting as multiple brain metastases. An epidermal growth factor receptor mutation analysis of his lung cancer… CONTINUE READING